PYY3 and obesity disorder: Specifically, while obesity surgery and LIRA/PYY3-36 co-administration resulted in comparable changes in body weight in obese rats, only surgery resulted in profound changes to the hypothalamic transcriptome; these findings may explain in part the limited nature of the metabolic improvements observed in response to pharmacologic intervention2,10.